Ticker Details
Atea Pharmaceuticals, Inc.
IPO Date:	October 30, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$435.51M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.40 | 3.03%
Avg Daily Range (30 D):	$0.16 | 3.25%
Avg Daily Range (90 D):	$0.14 | 2.75%

Institutional Daily Volume
Avg Daily Volume:	.65M
Avg Daily Volume (30 D):	.27M
Avg Daily Volume (90 D):	.25M

Trade Size
Avg Trade Size (Sh.):	114
Avg Trade Size (Sh.) (30 D):	67
Avg Trade Size (Sh.) (90 D):	62

Institutional Trades
Total Institutional Trades:	755
Avg Institutional Trade:	$1.94M
Avg Institutional Trade (30 D):	$.75M
Avg Institutional Trade (90 D):	$1.31M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.55M
Avg Closing Trade (30 D):	$.75M
Avg Closing Trade (90 D):	$1.58M
Avg Closing Volume:	188.26K

News

May 27, 2026 @ 11:00 AM Atea Pharmaceuticals Presents New Drug-Drug Intera... Source: Na

Feb 24, 2026 @ 12:00 PM Atea Pharmaceuticals Presents Preclinical Results ... Source: Na

Nov 7, 2025 @ 1:00 PM Atea Pharmaceuticals Presents New Data Supporting ... Source: Atea Pharmaceuticals

Nov 5, 2025 @ 12:00 PM Atea Pharmaceuticals to Host Third Quarter 2025 Fi... Source: Jonae Barnes

Jul 31, 2025 @ 11:00 AM Atea Pharmaceuticals to Host Second Quarter 2025 F... Source: Atea Pharmaceuticals

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-2.09	$-.41	$-.57
Diluted EPS	$-2.09	$-.41	$-.57
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-165.29M	$-32.93M	$-45.44M
Operating Income / Loss	$-183.61M	$-35.1M	$-48.01M
Cost of Revenue
Net Cash Flow	$-11.17M	$-2.77M	$-16.4M
PE Ratio

Splits
Feb 14, 2018	1:11